Patterns of Initiation of Oral Anticoagulants in Patients with Atrial Fibrillation— Quality and Cost Implications

Abstract Background Dabigatran, rivaroxaban, and apixaban have been approved for use in patients with atrial fibrillation based upon randomized trials demonstrating their comparable or superior efficacy and safety relative to warfarin. Little is known about their adoption into clinical practice, whe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of medicine 2014-11, Vol.127 (11), p.1075-1082.e1
Hauptverfasser: Desai, Nihar R., MD, MPH, Krumme, Alexis A., MS, Schneeweiss, Sebastian, MD, ScD, Shrank, William H., MD, MSHS, Brill, Gregory, MS, Pezalla, Edmund J., MD, MPH, Spettell, Claire M., PhD, Brennan, Troyen A., MD, JD, MPH, Matlin, Olga S., PhD, Avorn, Jerry, MD, Choudhry, Niteesh K., MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!